Clinical trial
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally…
NCT00088985 · UNC Lineberger Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00088985 |
|---|---|
| Title | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer |
| Official title | Phase II Trial Evaluating The Efficacy Of A Multiepitope Dendritic Cell Vaccine Given With Trastuzumab And Vinorelbine For The Treatment Of Women With Metastatic Breast Cancer That Express HLA-A0201 |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Susan G. Komen Breast Cancer Foundation |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | therapeutic autologous dendritic cells, trastuzumab, vinorelbine ditartrate |
| Enrollment | 56 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Aug 5, 2004 |
| Last update posted | Jun 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: